CompletedPhase 3NCT02987257
NATIENS: Optimal Management and Mechanisms of SJS/TEN
Studying Stevens-Johnson syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Vanderbilt University Medical Center
- Principal Investigator
- Elizabeth J Phillips, MDVanderbilt University Medical Center
- Intervention
- Harmonized supportive care(drug)
- Enrollment
- 2 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2025
Study locations (14)
- Valleywise Health Medical Center, Phoenix, Arizona, United States
- University of California, Davis Medical Center, Sacramento, California, United States
- MedStar Washington Hospital Center, Washington D.C., District of Columbia, United States
- University of Florida Health Burn Center, Gainesville, Florida, United States
- University of Miami, Ryder Trauma Center, Miami, Florida, United States
- Emory University at Grady Memorial Hospital, Atlanta, Georgia, United States
- Loyola University Medical Center, Maywood, Illinois, United States
- Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States
- Wayne State University, Detroit, Michigan, United States
- University of Tennessee Health Sciences Center, Memphis, Tennessee, United States
- Vanderblt University Medical Center, Nashville, Tennessee, United States
- University of Texas Southwestern Medical Center, Dallas, Texas, United States
- University of Texas Medical Branch, Galveston, Texas, United States
- University of Washington, Harborview Medical Center, Seattle, Washington, United States
Collaborators
University of Ottawa · University of Toronto
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02987257 on ClinicalTrials.gov